Sign in
CompletedNo phase

iotaSOFT Pediatric Study

Key facts

Who runs it
iotaMotion, Inc.
Where
Houston and Iowa City, United StatesSee the 2 sites
Trial code
Status
Completed
People taking part
20 people enrolled
Started
17 May 2022
Ended
10 Jul 2025
Type of study
Interventional
Treatments tested
  • iotaSOFT Insertion System
Record updated
6 August 2026

Who can take part

Age
9 months to 12 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Candidate for unilateral or bilateral cochlear implantation according to indications for use with FDA approved cochlear implant devices
  • Age 9 months to less than 12 years old at the time of CI surgery
  • Willingness to participate in the study and able to comply with the follow-up visit requirements

Who cannot take part

  • Prior cochlear implantation in the ear to be implanted
  • Planned or current participation in a clinical study of an investigational device or drug
  • Active middle-ear infection or tympanic membrane perforation in the presence of active middle-ear disease
  • Ossification or any other cochlear anomaly that might prevent complete insertion of the electrode array or present an increased risk of aberrant insertion
  • Craniofacial abnormality, temporal squamosal skull thickness less than 3mm, major cochlear lesions, or cochlear malformations
  • Deafness due to lesions of the acoustic nerve or central auditory pathway
  • Diagnosis of auditory neuropathy
  • Absence of cochlear development
  • Additional medical concerns that would prevent participation in evaluations as determined by the investigator

Where in United States

  • Texas Childrens HospitalHouston, United States
  • University of IowaIowa City, United States

About the trial

What the trial wants to find out

Prospective, non-randomized, open-label study to evaluate the safety and efficacy of the iotaSOFT Insertion System when used to assist electrode array insertion during cochlear implant surgery in a pediatric population.

The group in the trial

  • Pediatric Cochlear Implant RecipientTreatment being tested

    Pediatric subjects receiving a cochlear implant between the ages of 9 months and under 12 years of age who meet prescribed inclusion and exclusion criteria per protocol, signing and Informed Consent and completing active study period; enrollment through 30 days post cochlear implant surgery/activation per investigator site standard of care

    Treatment: iotaSOFT Insertion System

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
iotaSOFT Insertion System for Use With Cochlear Implant Surgery in Pediatrics
Record updated
6 August 2026